Pilot trial of sustained-release octreotide [PT 201] in Canada
Latest Information Update: 11 Feb 2014
At a glance
- Drugs Octreotide (Primary)
- Indications Acromegaly
- Focus Adverse reactions
- 11 Feb 2014 This pilot trial is being currently implemented in Canada, according to the Peptron website.
- 11 Feb 2014 New trial record